Cancer Prevention and Treatment Among African American Older Adults: Screening Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,593
- 试验地点
- 2
- 主要终点
- Difference between the two intervention groups in the proportion of participants who complete at least one of the recommended screenings.
研究概览
简要总结
The Centers for Medicare and Medicaid Services (CMS) has awarded cooperative agreements to 6 sites from across the country (Salt Lake City, UT, Molokai, HI, Houston, TX, Newark, NJ, Detroit, MI, and Baltimore City) to participate in a national 4-year demonstration (September 15, 2006 to September 30, 2010). One goal of the demonstration is to reduce disparities in cancer screening among seniors from U.S. racial and ethnic minority populations. Each site will focus on a specific racial/ethnic minority group, and collaborate with CMS in project implementation. A Core questionnaire, the Cancer Screening Assessment (CSA) will be administered at baseline to all participants in the demonstration. Participant identification, randomization, and intervention implementation will be standardized across sites.
Goal: The proposal developed by the Johns Hopkins Bloomberg School of Public Health in collaboration with the Baltimore City Community Health Coalition is designed to address persistent disparities in screening for breast, cervix, colon/rectum and prostate cancer among Baltimore City's seniors.
Primary Objective: Conduct a randomized controlled trial (target N = 2,874) within a project, to compare the efficacy of 2 interventions that differ in intensity to improve continuity and outcomes of care among African Americans seniors.
Among African American seniors, compared to a less intensive intervention (general information and educational materials), does the addition of facilitation services delivered by a health coordinator result in a greater improvement in adherence to cancer screening recommendations among those who are not known to have cancer?
Study Population: We will recruit African American residents of Baltimore, age 65 years or older, and currently enrolled in Medicare Parts A and B. (Baltimore City's 82,202 seniors represent 13% of its population, and account for 68% of the City's cancer deaths. Among these seniors, 96% have Medicare Parts A and B, 54.5% have income levels at less than 250% of the federal poverty guideline, and 55.6% are African American.)
Eligible participants will respond to a baseline questionnaire, Cancer Screening Assessment (CSA). They will then be randomized to receive a less intensive or more intensive intervention. The less intensive group will receive general information about cancer and Medicare covered services, and instructions to discuss the information with their primary care doctor. The more intensive group will receive the same information as the less intensive group receives, plus tailored facilitation services delivered by a nurse-supervised community health worker. The primary outcome variable will be the difference between randomized groups in adherence to screening for breast, cervix, colon/rectum and prostate cancer.
A community advisory committee will guide all aspects of the study and will include important stake holders (both public and private sectors), representatives from the Baltimore City Community Health Coalition, the Baltimore City Department of Health, the Maryland Department of Health and Mental Hygiene, community leaders, consumers, health care providers (physicians, oncologists, nurse practitioners, physician assistants, nurses, social workers, pathologists) and academicians.
详细描述
Among African American seniors, compared to a less intensive intervention (general information and educational materials), does the addition of facilitation services delivered by a health coordinator result in a greater improvement in adherence to cancer screening recommendations among those who are not known to have cancer?
Background
The Centers for Medicare and Medicaid Services (CMS) received congressional authorization to launch a nationwide demonstration project to address persistent disparities in cancer prevention among racial and ethnic minority populations. Hopkins was selected as one of six national sites to conduct a demonstration project designed to test an intervention strategy to promote adherence to cancer screening among African American seniors residing in Baltimore.
Aim
This demonstration project will evaluate the efficacy of a health coordinator model in cancer screening for older African American adults in Baltimore, Maryland.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Screening
- 盲法
- None
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age 65 or older;
- •Residence in Baltimore;
- •Enrolled in Medicare Part A;
- •Enrolled in Medicare Part B of Title XVIII of the Social Security Act;
- •Provided informed consent;
- •Must be free from cancer or in remission for 5 years or more
排除标准
- •Age less than 65;
- •Residence outside of Baltimore;
- •Enrollment in Medicare managed care (Part C);
- •Residence in a chronic care facility or otherwise institutionalized;
- •Planning to move within the next year;
- •Unable or unwilling to give informed consent;
- •Diagnosed with cancer within 5 years or less;
- •Diagnosed with cancer more than 5 years ago, but cancer in remission for less than 5 years
结局指标
主要结局
Difference between the two intervention groups in the proportion of participants who complete at least one of the recommended screenings.
时间窗: Number of days from date of randomization to date of completion of participation in the study
次要结局
- Adherence to maintenance screening.(Number of days beyond extended window for completion of a specific screening test)
- Improved utilization of Medicare-covered preventive services.(From date of randomization to date of completion of participation in the study)
- Timely notification of abnormal screening results.(Number of days between detection of an abnormal screening result and participant notification about the results)
- Stage at diagnosis.(At the time of diagnosis)
- Timely follow up with specialist following abnormal screening result.(From date of detection of an abnormal screening result to date of visit with specialist)
- Timely diagnosis following abnormal result.(From date of detection of an abnormal screening result to date of diagnosis)
- Timely treatment start-up.(Number of days from the date of diagnosis to date of initiation of therapy)